LACUTAMAB IN PATIENTS (PTS) WITH ADVANCED MYCOSIS FUNGOIDES (MF) ACCORDING TO KIR3DL2 EXPRESSION: EARLY RESULTS FROM THE TELLOMAK PHASE 2 TRIAL. (17th June 2021)

Record Type:: Journal Article
Title:: LACUTAMAB IN PATIENTS (PTS) WITH ADVANCED MYCOSIS FUNGOIDES (MF) ACCORDING TO KIR3DL2 EXPRESSION: EARLY RESULTS FROM THE TELLOMAK PHASE 2 TRIAL. (17th June 2021)
Main Title:: LACUTAMAB IN PATIENTS (PTS) WITH ADVANCED MYCOSIS FUNGOIDES (MF) ACCORDING TO KIR3DL2 EXPRESSION: EARLY RESULTS FROM THE TELLOMAK PHASE 2 TRIAL
Authors:: Bagot, M.
Kim, Y.
Zinzani, P. L.
Dalle, S.
Beylot‐barry, M.
Ortiz‐Romero, P. L
Cambalia, A.
Dereure, O.
Mortier, L.
Jacobsen, E.
Rotolo, F.
Azim, H. A
Porcu, P.
Abstract:
Is Part Of:: Hematological oncology. Volume 39(2021)Supplement 2
Journal:: Hematological oncology
Issue:: Volume 39(2021)Supplement 2
Issue Display:: Volume 39, Issue 2 (2021)
Year:: 2021
Volume:: 39
Issue:: 2
Issue Sort Value:: 2021-0039-0002-0000
Page Start:: n/a
Page End:: n/a
Publication Date:: 2021-06-17
Subjects:: Cutaneous non‐Hodgkin lymphoma Molecular Targeted Therapies
Hematological oncology -- Periodicals
Hematology
Medical Oncology
616.99418005
Journal URLs:: http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/hon.54_2879 ↗
Languages:: English
ISSNs:: 0278-0232
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4291.550000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 25334.xml